Therapy options for retinitis pigmentosa

Bibliography

• Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet 2006;368:1795-809
   PubMed Web of Science ®Google Scholar
• Hayakawa M, Fujiki K, Kanai A, et al. Multicenter genetic study of retinitis pigmentosa in Japan: I. Genetic heterogeneity in typical retinitis pigmentosa. Jpn J Ophthalmol 1997;41:1-6
   PubMed Web of Science ®Google Scholar
• Tsujikawa M, Wada Y, Sukegawa M, et al. Age at onset of retinitis pigmentosa. Arch Ophthalmol 2008;126:337-40
   PubMedGoogle Scholar
• Tanino T, Ohba N. Studies on pigmentary retinal dystrophy. I. Age of onset of subjective symptoms and the mode of inheritance. Jpn J Ophthalmol 1976;20:474-81
   Web of Science ®Google Scholar
• Bittner AK, Iftikkar H, Dagnelie G. Test-retest, within-visit variability of Goldmann visual fields in retinitis pigmentosa. Invest Ophthalmol Vis Sci 2011;52:8042-6
   PubMed Web of Science ®Google Scholar
• Iijima H. Correlation between visual sensitivity loss and years affected for eyes with retinitis pigmentosa. Jpn J Ophthalmol 2012;56:224-9
   PubMed Web of Science ®Google Scholar
• Sandberg MA, Weigel-DiFranco C, Rosner B, et al. The relationship between visual field size and electroretinogram amplitude in retinitis pigmentosa. Invest Ophthalmol Vis Sci 1996;37:1693-8
   PubMed Web of Science ®Google Scholar
• Rangaswamy NV, Patel HM, Locke KG, et al. A comparison of visual field sensitivity to photoreceptor thickness in retinitis pigmentosa. Invest Ophthalmol Vis Sci 2010;51:4213-19
   PubMed Web of Science ®Google Scholar
• Dryja TP, McGee TL, Reichel E, et al. A point mutation of the rhodopsin gene in one form of retinitis pigmentosa. Nature 1990;343:364-6
   PubMed Web of Science ®Google Scholar
• RetNet: genes and mapped loci causing retinal diseases. Available from: https://sph.uth.edu/retnet/disease.htm
   Google Scholar
• Audo I, Sahel JA, Mohand-Saïd S, et al. EYS is a major gene for rod-cone dystrophies in France. Hum Mutat 2010;31:E1406-35
   PubMed Web of Science ®Google Scholar
• Hosono K, Ishigami C, Takahashi M, et al. Two novel mutations in the EYS gene are possible major causes of autosomal recessive retinitis pigmentosa in the Japanese population. PLoS One 2012;7:e31036
   PubMed Web of Science ®Google Scholar
• Iwanami M, Oshikawa M, Nishida T, et al. High prevalence of mutations in the EYS gene in Japanese patients with autosomal recessive retinitis pigmentosa. Invest Ophthalmol Vis Sci 2012;53:1033-40
   PubMed Web of Science ®Google Scholar
• Chang GQ, Hao Y, Wong F. Apoptosis: final common pathway of photoreceptor death in rd, rds, and rhodopsin mutant mice. Neuron 1993;11:595-605
   PubMed Web of Science ®Google Scholar
• Sancho-Pelluz J, Arango-Gonzalez B, Kustermann S, et al. Photoreceptor cell death mechnisms in inherited retinal degeneration. Mol Neurobiol 2008;38:253-69
   PubMed Web of Science ®Google Scholar
• Trifunović D, Sahaboglu A, Kaur J, et al. Neuroprotective strategies for the treatment of inherited photoreceptor degeneration. Curr Mol Med 2012;12:598-612
   PubMed Web of Science ®Google Scholar
• Sharma AK, Rohrer B. Calcium-induced calpain mediated apoptosis via caspase-3 in a mouse photoreceptor cell line. J Biol Chem 2004;279:35564-72
   PubMed Web of Science ®Google Scholar
• Boujard H, Gubkina O, Robert N, et al. AIF-mediated programmed necrosis. Cell Cycle 2007;6:2612-19
   PubMed Web of Science ®Google Scholar
• Lolley RN, Schmidt SY, Farber DB. Alterations in cyclic AMP metabolism associated with photoreceptor cell degeneration in the C3H mouse. J Neurochem 1974;22:701-7
   PubMed Web of Science ®Google Scholar
• Weiss ER, Hao Y, Dickerson CD, et al. Altered cAMP levels in retinas from transgenic mice expressing a rhodopsin mutant. Biochem Biophys Res Commun 1995;216:755-61
   PubMed Web of Science ®Google Scholar
• Shinde VM, Sizova OS, Lin JH, et al. ER stress in retinal degeneration in S334ter Rho rats. PLoS One 2012;7:e33266; 1-14
   PubMed Web of Science ®Google Scholar
• Sanz MM, Johnson LE, Ahuja S, et al. Significant photoreceptor rescue by treatment with a combination of antioxidants in an animal model for retinal degeneration. Neuroscience 2007;145:1120-9
   PubMed Web of Science ®Google Scholar
• Fox DA, Poblenz AT, He L. Calcium overload triggers rod photoreceptor apoptotic cell death in chemical-induced and inherited retinal degenerations. Ann NY Acad Sci 1999;893:282-5
   PubMed Web of Science ®Google Scholar
• Doonan F, Donovan M, Cotter TG. Activation of multiple pathways during photoreceptor apoptosis in the rd mouse. Invest Ophthalmol Vis Sci 2005;46:3530-8
   PubMed Web of Science ®Google Scholar
• Nakazawa M. Effects of calcium ion, calpains and calcium channel blockers on retinitis pigmentosa. J Ophthalmol 2011;2011:article ID 292040
   Web of Science ®Google Scholar
• Paquet-Durand F, Azadi S, Hauck SM, et al. Calpain is activated in degenerating photoreceptors in the rd1 mouse. J Neurochem 2006;96:802-14
   PubMed Web of Science ®Google Scholar
• Mizukoshi S, Nakazawa M, Sato K, et al. Activation of mitochondrial calpain and release of apoptosis-inducing factor from mitochondria in RCS rat retinal degeneration. Exp Eye Res 2010;91:353-61
   PubMed Web of Science ®Google Scholar
• Paquet-Durand F, Silva J, Talukdar T, et al. Excessive activation of poly(ADP-ribose) polymerase contributes to inherited photoreceptor degeneration in the retinal degeneration 1 mouse. J Neurosci 2007;27:10311-19
   PubMed Web of Science ®Google Scholar
• Doonan F, Donovan M, Cotter TG. Caspase-independent photoreceptor apoptosis in mouse models of retinal degeneration. J Neurosci 2003;23:5723-31
   PubMed Web of Science ®Google Scholar
• Takeda H, Kitaoka Y, Hayashi Y, et al. Calcium/calmodulin-dependent protein kinase II regulates the phosphorylation of CREB in NMDA-induced retinal neurotoxicity. Brain Res 2007;1184:306-15
   PubMed Web of Science ®Google Scholar
• Sheikh MS, Fornace AJ Jr. Role of p53 family members in apoptosis. J Cell Physiol 2000;182:171-81
   PubMed Web of Science ®Google Scholar
• Faktorovich EG, Steinberg RH, Yasumura D, et al. Photoreceptor degeneration in inherited retinal dystrophy delayed by basic fibroblast growth factor. Nature 1990;347:83-6
   PubMed Web of Science ®Google Scholar
• Cayouette M, Gravel C. Adenovirus-mediated gene transfer of ciliary neurotrophic factor can prevent photoreceptor degeneration in the retinal degeneration (rd) mouse. Hum Gene Ther 1997;8:423-30
   PubMed Web of Science ®Google Scholar
• Cayouette M, Behn D, Sendtner M, et al. Intraocular gene transfer of ciliary neurotrophic factor prevents death and increases responsiveness of rod photoreceptors in the retinal degeneration slow mouse. J Neurosci 1998;18:9282-93
   PubMed Web of Science ®Google Scholar
• Wen R, Tao W, Lin Y, et al. CNTF and retina. Prog Retin Eye Res 2012;31:136-51
   PubMed Web of Science ®Google Scholar
• Cayouette M, Smith SB, Becerra SP, et al. Pigment epithelium-derived factor delays the death of photoreceptors in mouse models of inherited retinal degenerations. Neurobiol Dis 1999;6:523-32
   PubMed Web of Science ®Google Scholar
• Lambiase A, Aloe L. Nerve growth factor delays retinal degeneration in C3H mice. Graefes Arch Clin Exp Ophthalmol 1996;234(Suppl 1):S96-100
   PubMed Web of Science ®Google Scholar
• Lenzi L, Coassin M, Lambiase A, et al. Effect of exogenous administration of nerve growth factor in the retina of rats with inherited retinitis pigmentosa. Vision Res 2005;45:1491-500
   PubMed Web of Science ®Google Scholar
• Léveillard T, Mohand-Saïd S, Lorentz O, et al. Identification and characterization of rod-derived cone viability factor. Nat Genet 2004;36:755-9
   PubMed Web of Science ®Google Scholar
• Arroba AI, Wallace D, Mackey A, et al. IGF-I maintains calpastatin expression and attenuates apoptosis in several models of photoreceptor cell death. Eur J Neurosci 2009;30:975-86
   PubMed Web of Science ®Google Scholar
• Stieger K, Lorenz B. Gene therapy for vision loss – recent developments. Discov Med 2010;10:425-33
   PubMed Web of Science ®Google Scholar
• Acland GM, Aguirre GD, Ray J, et al. Gene therapy restores vision in a canine model of childhood blindness. Nat Genet 2001;28:92-5
   PubMed Web of Science ®Google Scholar
• Bainbridge JW, Smith AJ, Barker SS, et al. Effect of gene therapy on visual function in Leber’s congenitalamaurosis. N Engl J Med 2008;358:2231-9
   PubMed Web of Science ®Google Scholar
• Maguire AM, Simonelli F, Pierce EA, et al. Safety and efficacy of gene transfer for Leber’s congenital amaurosis. N Engl J Med 2008;358:2240-8
   PubMed Web of Science ®Google Scholar
• Cideciyan AV, Aleman TS, Boye SL, et al. Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics. Proc Natl Acad Sci USA 2008;105:15112-17
   PubMed Web of Science ®Google Scholar
• Cideciyan AV, Hauswirth WW, Aleman TS, et al. Vision 1 year after gene therapy for Leber’s congenital amaurosis. N Engl J Med 2009;361:725-7
   PubMed Web of Science ®Google Scholar
• Jacobson SG, Cideciyan AV, Ratnakaram R, et al. Gene Therapy for Leber congenital amaurosis caused by RPE65 mutations. Safety and efficacy in 15 children and adults followed up to 3 years. Arch Ophthalmol 2012;130:9-24
   PubMed Web of Science ®Google Scholar
• Banin E, Bandah-Rozenfeld D, Obolensky A, et al. Molecular anthropology meets genetic medicine to treat blindness in the North African Jewish population: human gene therapy initiated in Israel. Hum Gene Ther 2010;21:1749-57
   PubMed Web of Science ®Google Scholar
• Tomita H, Sugano E, Yawo H, et al. Restoration of visual response in aged dystrophic RCS rats using AAV-mediated channelopsin-2 gene transfer. Invest Ophthalmol Vis Sci 2007;48:3821-6
   PubMed Web of Science ®Google Scholar
• Berson EL, Rosner B, Sandberg MA, et al. A randomized clinical trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol 1993;111:761-72
   PubMed Web of Science ®Google Scholar
• Berson EL. Long-term visual prognoses in patients with retinitis pigmentosa: the Ludwig von Sallmann lecture. Exp Eye Res 2007;85:7-14
   PubMed Web of Science ®Google Scholar
• Massof RW, Finkelstein D. Supplemental vitamin A retards loss of ERG amplitude in retinitis pidmentosa. Arch Ophthalmol 1993;111:751-4
   PubMedGoogle Scholar
• Kijlstra A, Tian Y, Kelly ER, et al. Lutein: more than just a filter for blue light. Prog Retin Eye Res 2012;31:303-15
   PubMed Web of Science ®Google Scholar
• Rapp LM, Maple SS, Choi JH. Lutein and zeaxanthin concentrations in rod outer segment membranes from perifoveal and peripheral human retina. Invest Ophthalmol Vis Sci 2000;41:1200-9
   PubMed Web of Science ®Google Scholar
• Khachik F, Bernstein PS, Garland PL. Identification of lutein and zeaxanthin oxidation products in human and monkey retinas. Invest Ophthalmol Vis Sci 1997;38:1802-11
   PubMed Web of Science ®Google Scholar
• Seddon JM, Ajani UA, Sperduto RD, et al. Eye Disease Case-Control Study Group. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. JAMA 1994;272:1413-20
   PubMed Web of Science ®Google Scholar
• Hayano S, Koide Y, Ashizawa K, et al. Actions of adaptinol observed from blood lutein pattern (in Japanese). Rinsho Ganka (Jpn J Clin Ophthalmol) 1959;13:931-7
   Google Scholar
• Sandberg MA, Johnson EJ, Berson EL. The relationship of macular pigment optical density to serum lutein in retinitis pigmentosa. Invest Ophthalmol Vis Sci 2010;51:1086-91
   PubMed Web of Science ®Google Scholar
• Aleman TS, Duncan JL, Bieber ML, et al. Macular pigment and lutein supplementation in retinitis pigmentosa and Usher syndrome. Invest Ophthalmol Vis Sci 2001;42:1873-8
   PubMed Web of Science ®Google Scholar
• Duncan JL, Aleman TS, Gardner LM, et al. Macular pigment and lutein supplementation in choroideremia. Exp Eye Res 2002;74:371-81
   PubMed Web of Science ®Google Scholar
• Bahrami H, Melia M, Dagnelie G. Lutein supplementation in retinitis pigmentosa: PC-based vision assessment in a randomized double-masked placebo-controlled clinical trial [NCT00029289]. BMC Ophthalmol 2006;6:23
   PubMedGoogle Scholar
• Berson EL, Rosner B, Sandberg MA, et al. Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A. Arch Ophthalmol 2010;128:403-11
   PubMed Web of Science ®Google Scholar
• Massof RW, Fishman GA. How strong is the evidence that nutritional supplements slow the progression of retinitis pigmentosa? Arch Ophthalmol 2010;128:493-5
   PubMedGoogle Scholar
• Fiesler SJ, Anderson RE. Chemistry and metabolism of lipids in the vertebrate retina. Prog Lipid Res 1983;22:79-131
   PubMed Web of Science ®Google Scholar
• Hoffman DR, Birch DG. Docosahexaenoic acid in red blood cells of patients with X-linked retinitis pigmentosa. Invest Ophthalmol Vis Sci 1995;36:1009-18
   PubMed Web of Science ®Google Scholar
• Berson EL, Rosner B, Sandberg MA, et al. Omega-3 intake and visual acuity in patients with retinitis pigmentosa on vitamin A. Arch Ophthalmol 2012;130:707-11
   PubMedGoogle Scholar
• Seigel D, Richoz O. Omega-3 intake and visual acuity in patients with retinitis pigmentosa on vitamin A. JAMA Ophthalmol 2013;131:267-8
   PubMed Web of Science ®Google Scholar
• Van Hooser JP, Aleman TS, He YG, et al. Rapid restoration of visual pigment and function with oral retinoid in a mouse model of childhood blindness. Proc Natl Acad Sci USA 2000;97:8623-8
   PubMed Web of Science ®Google Scholar
• Maeda T, Dong Z, Jin H, et al. QLT091001, a 9-cis-retinal analog, is well-tolerated by retinas of mice with impaired visual cycles. Invest Ophthalmol Vis Sci 2013;54:455-66
   PubMed Web of Science ®Google Scholar
• Sato K, Nakazawa M, Takeuchi K, et al. S-opsin protein is incompletely modified during N-glycan processing in Rpe65-/- mice. Exp Eye Res 2010;91:54-62
   PubMed Web of Science ®Google Scholar
• Sato K, Ozaki T, Ishiguro S, et al. M-opsin protein degradation is inhibited by MG-132 in RPE65-/- retinal explant. Mol Vis 2012;18:1516-25
   PubMed Web of Science ®Google Scholar
• Cideciyan AV, Moore AT, Zrenner E, et al. Increased vision within days of oral cis-retinoid (QLT091001) treatment in blindness due to mutations in retinal pigment epithelium-specific protein 65kDa (REP65) or lecithin retinol acyltransferase (LRAT) [abstract #6965]. ARVO 2012; 2012
   Google Scholar
• Koenekoop RK, Esteban E, Wood L, et al. Update on QLT091001 in subjects with Leber congenital amaurosis (LCA) due to lecithin:retinol acyltransferase (LRAT) or retinal pigment epithelial 65 protein (RPE65) mutations: Longer-term follow-up of subjects originally treated with 7-day therapy [abstract #4642]. ARVO 2012; 2012
   Google Scholar
• Rotenstreich Y, Belkin M, Sadetzki S, et al. Treatment with 9-cis beta-carotene-rich powder in patients with retinitis pigmentosa. A randomized crossover trial. JAMA Ophthalmol 2013;131:985-92
   PubMed Web of Science ®Google Scholar
• Tao W. Application of encapsulated cell technology for retinal degenerative diseases. Expert Opin Biol Ther 2006;6:717-26
   PubMedGoogle Scholar
• Tao W, Wen R, Goddard MB, et al. Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosa. Invest Ophthalmol Vis Sci 2002;43:3292-8
   PubMed Web of Science ®Google Scholar
• Sieving PA, Caruso RC, Tao W, et al. Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants. Proc Natl Acad Sci USA 2006;103:3896-901
   PubMed Web of Science ®Google Scholar
• Kauper K, McGovern C, Sherman S, et al. Two-year intraocular delivery of ciliary neurotrophic factor by encapsulated cell technology implants in patients with chronic retinal degenerative diseases. Invest Ophthalmol Vis Sci 2012;53:7484-91
   PubMed Web of Science ®Google Scholar
• Talcott KE, Ratnam K, Sundquist SM, et al. Longitudinal study of cone photoreceptors during retinal degeneration and in response to ciliary neurotrophic factor treatment. Invest Ophthalmol Vis Sci 2011;52:2219-26
   PubMed Web of Science ®Google Scholar
• Birch DG, Weleber RG, Duncan JL, et al. Randomized trial of ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for retinitis pigmentosa. Am J Ophthalmol 2013;156:283-92
   PubMed Web of Science ®Google Scholar
• Miyazaki M, Ikeda Y, Yonemitsu Y, et al. Synergistic neuroprotective effect via simian lentiviral vector-mediated simultaneous gene transfer of human pigment epithelium-derived factor and human fibroblast growth factor-2 in rodent models of retinitis pigmentosa. J Gene Med 2008;10:1273-81
   PubMed Web of Science ®Google Scholar
• Buch PK, MacLaren RE, Duran Y, et al. In contrast to AAV-mediated Cntf expression, AAV-mediated Gdnf expression enhances gene replacement therapy in rodent models of retinal degeneration. Mol Ther 2006;14:700-9
   PubMed Web of Science ®Google Scholar
• Rex TS, Allocca M, Domenici L, et al. Systemic but not intraocular Epo gene transfer protects the retina from light-and geneticinduced degeneration. Mol Ther 2004;10:855-61
   PubMed Web of Science ®Google Scholar
• Leonard KC, Petrin D, Coupland SG, et al. XIAP protection of photoreceptors in animal models of retinitis pigmentosa. PLoS One 2007;2:e314
   PubMed Web of Science ®Google Scholar
• Ikeda Y, Yonemitsu Y, Miyazaki M, et al. Stable retinal gene expression in nonhuman primates via subretinal injection of SIVagm-based lentiviral vectors. Hum Gene Ther 2009;20:573-9
   PubMed Web of Science ®Google Scholar
• Frasson M, Sahel JA, Fabre M, et al. Retinitis pigmentosa: rod photoreceptor rescue by a calcium-channel blocker in the rd mouse. Nat Med 1999;5:1183-7
   PubMed Web of Science ®Google Scholar
• Takeuchi K, Nakazawa M, Mizukoshi S. Systemic administration of nilvadipine delays photoreceptor degeneration of heterozygous retinal degeneration slow (rds) mouse. Exp Eye Res 2008;86:60-9
   PubMed Web of Science ®Google Scholar
• Takano Y, Ohguro H, Dezawa M, et al. Study of drug effects of calcium channel blockers on degeneration of rd mouse. Biochem Biophys Res Commun 2004;313:1015-22
   PubMed Web of Science ®Google Scholar
• Nakazawa M, Ohguro H, Takeuchi K, et al. Effect of nilvadipine on central visual field in retinitis pigmentosa: a 30-month clinical trial. Ophthalmologica 2011;225:120-6
   PubMed Web of Science ®Google Scholar
• Nakazawa M, Suzuki Y, Ito T, et al. Long-term effects of nilvadipine against progression of the central visual field defect in retinitis pigmentosa: Extended study. Biomed Res Int 2013
   PubMed Web of Science ®Google Scholar
• Falsini B, Anselmi GM, Marangoni D, et al. Subfoveal choroidal blood flow and central retinal function in retinitis pigmentosa. Invest Ophthalmol Vis Sci 2011;22:1064-9
   Google Scholar
• Koseki N, Araie M, Tomidokoro A, et al. A placebo-controlled 3-year study of a calcium blocker on visual field and ocular circulation in glaucoma with low-normal pressure. Ophthalmology 2008;115:2049-57
   PubMed Web of Science ®Google Scholar
• Pasantes-Morales H, Quiroz H, Quesada O. Treatment with taurine, diltiazem, and vitamin E retards the progressive visual field reduction in retinitis pigmentosa: a 3-year follow-up study. Metab Brain Dis 2002;17:183-97
   PubMed Web of Science ®Google Scholar
• Clemson CM, Tzekov R, Krebs M, et al. Therapeutic potential of valproic acid for retinitis pigmentosa. Br J Ophthalmol 2011;95:89-93
   PubMed Web of Science ®Google Scholar
• Biermann J, Grieshaber P, Goebel U, et al. Valproic acid-mediated neuroprotection and regeneration in injured retinal ganglion cells. Invest Ophthalmol Vis Sci 2010;51:526-34
   PubMed Web of Science ®Google Scholar
• Sandberg MA, Rosner B, Weigel-DiFranco C, et al. Lack of scientific rationale for use of valproic acid for retinitis pigmentosa. Br J Ophthalmol 2011;95:744
   PubMed Web of Science ®Google Scholar
• Sisk RA. Valproic acid treatment may be harmful in non-dominant forms of retinitis pigmentosa. Br J Ophthalmol 2012;96:1154-5
   PubMed Web of Science ®Google Scholar
• Paquet-Durand F, Sanges D, McCall J, et al. Photoreceptor rescue and toxicity induced by different calpain inhibitors. J Neurochem 2010;115:930-40
   PubMed Web of Science ®Google Scholar
• Ozaki T, Nakazawa M, Yamashita T, et al. Intravitreal injection or topical eye-drop application of a mu-calpain C2L domain peptide protects against photoreceptor cell death in Royal College of Surgeons rats, a model of retinitis pigmentosa. Biochim Biophys Acta 2012;1822:1783-95
   PubMed Web of Science ®Google Scholar
• Ozaki T, Ishiguro S-I, Hirano S, et al. Inhibitory peptide of mitochondrial mu-calpain protects against photoreceptor degeneration in rhodopsin transgenic S334ter and P23H rats. PLoS One 2013;8:e71650
   PubMed Web of Science ®Google Scholar
• Boujrad H, Gubkina O, Robert N, et al. AIF-mediated programmed necrosis: a highly regulated way to die. Cell Cycle 2007;6:2612-19
   PubMed Web of Science ®Google Scholar
• Cuppoletti J, Malinowska DH, Tewari KP, et al. Cellular and molecular effects of unoprostone as a BK channel activator. Biochim Biophys Acta 2007;1768:1083-92
   PubMed Web of Science ®Google Scholar
• Tsuruma K, Tanaka Y, Shimazawa M, et al. Unoprostone reduces oxidative stress- and light-induced retinal cell death, and phagocytotic dysfunction, by activating BK channels. Mol Vis 2011;17:3556-65
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Sugawara T, Murakami A, et al. Topical isopropyl unoprostone for retinitis pigmentosa: microperimetric results of the phase 2 clinical study. Ophthalmol Ther 2012;1:5
   PubMedGoogle Scholar
• Merin S, Obolensky A, Farber MD, et al. A pilot study of topical treatment with an alpha2-agonist in patients with retinal dystrophies. J Ocul Pharmacol Ther 2008;24:80-6
   PubMed Web of Science ®Google Scholar
• Fishman GA, Gilbert LD, Fiscella RG, et al. Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa. Arch Ophthalmol 1989;107:1445-52
   PubMed Web of Science ®Google Scholar
• Cox SN, Hay E, Bird A. Treatment of chronic macular edema with acetazolamide. Arch Ophthalmol 1988;106:1190-5
   PubMed Web of Science ®Google Scholar
• Grover S, Apushkin MA, Fishman GA. Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa. Am J Ophthalmol 2006;141:850-8
   PubMed Web of Science ®Google Scholar
• Fishman GA, Gilbert LD, Anderson RJ, et al. Effect of methazolamide on chronic macular edema in patients with retinitis pigmentosa. Ophthalmology 1994;101:687-93
   PubMed Web of Science ®Google Scholar
• Ikeda Y, Hisatomi T, Yoshida N, et al. The clinical efficacy of a topical dorzolamide in the management of cystoid macular edema in patients with retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol 2012;250:809-14
   PubMed Web of Science ®Google Scholar
• Santos JL, Humayun MS, de Juan E, Jr, et al. Preservation of the inner retina in retinitis pigmentosa. A morphometric analysis. Arch Ophthalmol 1997;115:511-15
   PubMed Web of Science ®Google Scholar
• Humayun MS, de Juan E Jr, Dagnelie G, et al. Visual perception elicited by electrical stimulation of retina in blind humans. Arch Ophthalmol 1996;114:40-6
   PubMed Web of Science ®Google Scholar
• Menzel-Severing J, Laube T, Brockmann C, et al. Implantation and explantation of an active epiretinal visual prosthesis: 2-year follow-up data from the EPIRET3 prospective clinical trial. Eye 2012;21:501-9
   Google Scholar
• Ahuja AK, Behrend MR. The Argus™ II retinal prosthesis: factors affecting patient selection for implantation. Prog Retin Eye Res 2013;36:1-23
   PubMed Web of Science ®Google Scholar
• Fujikado T, Kamei M, Sakaguchi H, et al. Testing of semichronically implanted retinal prosthesis by suprachoroidal-transretinal stimulation in patients with retinitis pigmentosa. Invest Ophthalmol Vis Sci 2011;52:4726-33
   PubMed Web of Science ®Google Scholar
• Zrenner E, Bartz-Schmidt KU, Benav H, et al. Subretinal electronic chips allow blind patients to read letters and combine them to words. Proc Biol Sci 2010;278:1489-97
   PubMed Web of Science ®Google Scholar
• Rizzo JF III, Wyatt J, Loewenstein J, et al. Perceptual efficacy of electrical stimulation of human retina with a microelectrode array during short-term surgical trials. Invest Ophthalmol Vis Sci 2003;44:5362-9
   PubMed Web of Science ®Google Scholar
• Seiler M, Aramant RB, Ehinger B, et al. Transplantation of embryonic retina to adult retina in rabbits. Exp Eye Res 1990;51:225-8
   PubMed Web of Science ®Google Scholar
• Radtke ND, Seiler MJ, Aramant RB, et al. Transplantation of intact sheets of fetal neural retina with its retinal pigment epithelium in retinitis pigmentosa patients. Am J Ophthalmol 2002;133:544-50
   PubMed Web of Science ®Google Scholar
• Homma K, Okamoto S, Mandai M, et al. Developing rods transplanted into the degenerating retina of Crx-knockout mice exhibit neural activity similar to native photoreceptors. Stem Cells 2013;31:1149-59
   PubMed Web of Science ®Google Scholar
• Jin ZB, Okamoto S, Osakada F, et al. Modeling retinal degeneration using patient-specific induced pluripotent stem cells. PLoS One 2011;6:e17084
   PubMed Web of Science ®Google Scholar